Identifying low-risk cancer patients with pulmonary embolism for early discharge from the emergency department
Pulmonary Thromboembolism in Cancer Patients: Early Rule-out From the Emergency Department
IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06761144
This study is trying to find out which cancer patients with pulmonary embolism can safely go home early from the emergency department to avoid extra hospital time.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna (other) |
| Locations | 1 site (Bologna) |
| Trial ID | NCT06761144 on ClinicalTrials.gov |
What this trial studies
This observational study aims to evaluate the effectiveness of various assessment scales used by physicians to identify cancer patients at low risk of developing serious complications from pulmonary thromboembolism (PTE) within 30 days of diagnosis. By analyzing data from patients who presented to the Emergency Department with PTE, the study seeks to determine which patients can be safely discharged early, thereby reducing unnecessary hospital stays. The research will include both retrospective and prospective enrollment of patients diagnosed with PTE during their cancer treatment. The goal is to improve patient care and resource utilization in emergency medicine.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older with a diagnosis of pulmonary embolism and active onco-haematological disease.
Not a fit: Patients returning to the Emergency Department for complications related to previously diagnosed pulmonary embolism may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to safer early discharge protocols for low-risk cancer patients with pulmonary embolism, improving their quality of life and reducing hospital costs.
How similar studies have performed: While there have been studies on early discharge protocols for various conditions, this specific approach for cancer patients with pulmonary embolism is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 18 years * Diagnosis of pulmonary embolism (symptomatic and/or incidental) * Active onco-haematological disease (disease followed in oncological/haematological and/or metastatic setting) * Informed consent to the study Exclusion Criteria: * Patients returning to the Emergency Department for complications related to previously diagnosed pulmonary embolism
Where this trial is running
Bologna
- Eleonora Tubertini — Bologna, Italy (RECRUITING)
Study contacts
- Principal investigator: Eleonora Tubertini, MD — IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Study coordinator: Eleonora Tubertini, MD
- Email: eleonora.tubertini@aosp.bo.it
- Phone: +39 051943435
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Pulmonary Thromboembolisms